Search

everythinglearnresearchcommunity

for

Search:↓

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Identified genes linked to male-pattern baldness may help develop new treatments.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Metformin may help treat neuroendocrine tumors.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Common skin conditions can greatly affect a person's mental health and social life.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

PCOS symptoms vary by age, affecting diagnosis and treatment.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Tofacitinib is effective and safe for treating severe alopecia areata.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Nano-quercetin improves quercetin's effectiveness in treating diseases but faces challenges in safety and production.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

The risks of testosterone implants in women outweigh the benefits.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Lower ghrelin levels and certain gene variations may increase acne risk.

Good hair and scalp health indicate good overall health.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.